Evidence map›Paper›PMID 41129342›Full record

ArticleFEMS microbiology letters2025

Deciphering the microbiota compositions of complex biofilms from hospital and domestic settings across Estonia, Germany, and the United Kingdom.

Christina Killian, Guerrino Macori, Isabella Centeleghe, Peeter Laas, Rebecca Lewis, Nicole van Leuven, Katie Wall, Razan Abbara, Ralf Lucassen, Marja Hagström and 6 more

Abstract read
In one paragraph

Article in FEMS microbiology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Christina KillianUCD-Centre for Food Safety, University College Dublin, Dublin D05 N2E5, Ireland.
Guerrino MacoriUCD-Centre for Food Safety, University College Dublin, Dublin D05 N2E5, Ireland.
Isabella CentelegheSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, United Kingdom.
Peeter LaasInstitute of Technology, Tartu University, Nooruse 1, Tartu 50411, Estonia.
Rebecca LewisSchool of Life Sciences, Pharmacy and Chemistry, SEC Faculty, Kingston University London, Kingston Upon Thames, KT1 2EE, United Kingdom.
Nicole van LeuvenRhine-Waal University of Applied Sciences, Faculty of Life Sciences, Kleve, D-47533, Germany.
Katie WallUCD-Centre for Food Safety, University College Dublin, Dublin D05 N2E5, Ireland.
Razan AbbaraSchool of Life Sciences, Pharmacy and Chemistry, SEC Faculty, Kingston University London, Kingston Upon Thames, KT1 2EE, United Kingdom.
Ralf LucassenRhine-Waal University of Applied Sciences, Faculty of Life Sciences, Kleve, D-47533, Germany.
Marja HagströmFinnish Environment Institute, Latokartanonkaari 11, 00790 Helsinki, Finland.
Dirk BockmuehlRhine-Waal University of Applied Sciences, Faculty of Life Sciences, Kleve, D-47533, Germany.
Mark FielderSchool of Life Sciences, Pharmacy and Chemistry, SEC Faculty, Kingston University London, Kingston Upon Thames, KT1 2EE, United Kingdom.
Noora PerkolaFinnish Environment Institute, Latokartanonkaari 11, 00790 Helsinki, Finland.
Veljo KisandInstitute of Technology, Tartu University, Nooruse 1, Tartu 50411, Estonia.
Jean-Yves MalliardSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NB, United Kingdom.ORCID 0000-0002-8617-9288
Séamus FanningUCD-Centre for Food Safety, University College Dublin, Dublin D05 N2E5, Ireland.ORCID 0000-0002-1922-8836

Funding

Academy of FinlandDAFMJPIAMRMedical Research Council
6 · The paper itself

Abstract

Currently, there is a limited understanding of the microbiota composition of complex biofilms, in particular describing the abundance of bacterial genera, fungi, and yeasts with reference to the One Health axes. As a starting point, describing the microbiota found in these settings would begin to describe the nature of any biological hazards present and facilitate development of strategies to limit transmission and the spread of infection. Furthermore, using this approach, suitable interventional measures could then be tested in the laboratory-scale model for their efficacy and then applied in situ. COMplex Biofilms and AMR Transmission (COMBAT) is a consortium of research teams that studied the application of next-generation sequencing (NGS) strategies to identify bacterial, fungal, and yeast species present in selected biofilms recovered from drain settings found in domestic and hospital settings in four geographical regions. Findings from this study extended our understanding of the bacterial, fungal, and yeast abundances in these sample biofilms and how they may change following enrichment. A VSEARCH-based high-resolution clustering approach was implemented to full-length 16S rRNA (FL-16S) sequencing reads to generate near-ASV operational units, enabling detailed characterization of the microbial communities within complex biofilms. This analytical framework provides the basis for testing interventional measures at the laboratory scale that could be implemented to reduce risk to the One Health axes.

Indexed as

BacteriaBiofilmsFungiMicrobiotaEstoniaGermanyHigh-Throughput Nucleotide SequencingHospitalsHumansRNA, Ribosomal, 16SUnited KingdomYeastsRNA, Ribosomal, 16Sbiofilmnext-generation sequencingOne Health

Identifiers

PMID41129342
PMCPMC12604003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.